Table 4.

Multivariate Analysis of Factors Affecting Relapse

Favorable Variable Unfavorable Variable Risk Ratio (95% CI) P
Melphalan-TBI  Other  3.2 (1.8-5.6) .0001  
Day 29 lymphocyte count ≥0.2 × 109/L Day 29 lymphocyte count <0.2 × 109/L 2.9 (0.9-9.1)  .02  
FAB subtype M1-3  Other 1.6 (1.0-2.7)  .03  
Nucleated cell dose ≤2.42 × 108/kg  Nucleated cell dose >2.42 × 108/kg  1.7 (1.1-1.8)  .05 
Favorable Variable Unfavorable Variable Risk Ratio (95% CI) P
Melphalan-TBI  Other  3.2 (1.8-5.6) .0001  
Day 29 lymphocyte count ≥0.2 × 109/L Day 29 lymphocyte count <0.2 × 109/L 2.9 (0.9-9.1)  .02  
FAB subtype M1-3  Other 1.6 (1.0-2.7)  .03  
Nucleated cell dose ≤2.42 × 108/kg  Nucleated cell dose >2.42 × 108/kg  1.7 (1.1-1.8)  .05 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal